Clinical Trials Directory

Trials / Unknown

UnknownNCT03939338

Combination With Treg Levels and CMR to Assess the Severity and Prognosis of Reperfusion Injury After PPCI in STEMI Patients

Combination With Regulatory T Cell Levels and Cardiac Magnetic Resonance Imaging (CMR) to Assess the Severity and Prognosis of Reperfusion Injury After Primary PCI in STEMI Patients (TregCMRRS)

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Beijing Friendship Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study aims to determine whether combination with regulatory T cell (Treg) levels and cardiac magnetic resonance imaging (CMR) are predictive of the severity of reperfusion injury following myocardial infarction and the prognosis in STEMI patients receiving primary percutaneous coronary intervention (PPCI).

Conditions

Interventions

TypeNameDescription
OTHERTreg levels and CMR resultsThis is an observational study. Exposure: Different Treg levels and CMR results.

Timeline

Start date
2019-07-01
Primary completion
2021-08-31
Completion
2021-08-31
First posted
2019-05-06
Last updated
2019-06-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03939338. Inclusion in this directory is not an endorsement.